BVSBioventus Inc.

Nasdaq bioventus.com


$ 5.46 $ 0.42 (8.33 %)    

Thursday, 09-May-2024 15:59:50 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 5.46
$ 4.60
$ 0.00 x 0
$ 0.00 x 0
$ 4.60 - $ 5.48
$ 1.00 - $ 6.08
406,233
na
346.06M
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-30-2024 10-Q
2 03-12-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 07-01-2023 10-Q
5 05-16-2023 04-01-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-21-2022 10-01-2022 10-Q
8 08-12-2022 07-02-2022 10-Q
9 05-11-2022 04-02-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-10-2021 10-02-2021 10-Q
12 08-11-2021 07-03-2021 10-Q
13 05-13-2021 04-03-2021 10-Q
14 03-26-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-bioventus-raises-price-target-to-8

Canaccord Genuity analyst William Plovanic maintains Bioventus (NASDAQ:BVS) with a Buy and raises the price target from $7 t...

 bioventus-raises-2024-guidance-now-expects-net-sales-of-535m-550m-prior-520m-535m-vs-528033m-est-and-adj-eps-of-025-to-033-prior-012-020-vs-016-est

2024 Financial Guidance: Based on strong execution and significant momentum across the business, Bioventus is raising financia...

 bioventus-q1-2024-adj-eps-007-beats-007-estimate-sales-129457m-beat-118380m-estimate

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.07) by 2...

 blend-labs-reports-q4-results-joins-alta-equipment-despegarcom-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLN...

 craig-hallum-maintains-buy-on-bioventus-raises-price-target-to-9

Craig-Hallum analyst Alexander Nowak maintains Bioventus (NASDAQ:BVS) with a Buy and raises the price target from $6 to $9.

 why-asana-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

 bioventus-reports-upbeat-earnings-joins-ranpak-beachbody-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday.

 bioventus-q4-adjusted-eps-007-beats-002-estimate-sales-13542m-beat-12396m-estimate

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.02 by 250...

 earnings-scheduled-for-march-12-2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

 a-preview-of-bioventuss-earnings
A Preview Of Bioventus's Earnings
03/11/2024 17:01:51

 bioventus-names-robert-claypoole-as-president-ceo-and-a-member-of-its-board-effective-january-10-2024

Claypoole succeeds Anthony Bihl who has served as interim CEO and a director on the Board since April 2023.

 medtech-bioventus-stabilization-sparks-analyst-confidence-earns-upgrade-and-price-target-boost

Canaccord Genuity has upgraded Biomedical Devices and Services company Bioventus Inc (NASDAQ: BVS), highlighting greater insigh...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION